NEUROPACE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 182.94K shares, a 744.16% increase year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 41.60K shares, a 58.93% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 41.21K shares, a 10.18% increase year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 35.45K shares, a 132.32% increase year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 199.64K shares, a 64.14% decline from fiscal 2024.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 556.72K shares, a 37.45% decline from fiscal 2023.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 889.97K shares, a 465.25% increase from fiscal 2022.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 157.45K shares, a 47.65% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 182.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 301.21K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 41.60K shares 10-Q · filed 2026-05-12 | 139.94K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 41.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 199.64K shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 35.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 195.83K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 21.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 175.64K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 101.30K shares 10-Q · filed 2025-05-13 | 248.97K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 37.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 556.72K shares 10-K · filed 2025-03-04 |
| 2024-09-30 | 15.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 914.43K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-06-30 | 95.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.21M shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-03-31 | 409.05K shares 10-Q · filed 2024-05-08 | 1.28M shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-12-31 | 395.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 889.97K shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 313.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 523.10K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-06-30 | 164.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 226.12K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-03-31 | 17.61K shares 10-Q · filed 2023-05-04 | 136.42K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-12-31 | 28.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 157.45K shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 16.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 164.47K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 74.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 161.53K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 38.63K shares 10-Q · filed 2022-05-12 | 182.87K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 35.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 300.77K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 13.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | 95.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | 156.54K shares 10-Q · filed 2021-06-03 | |
| 2020-12-31 | 112.05K shares 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |